Trial Profile
A study comparing the effect of dabigatran and rivaroxaban and gastrointestinal bleeding risk in patients receiving either of the treatment
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Dec 2015
Price :
$35
*
At a glance
- Drugs Dabigatran etexilate (Primary) ; Rivaroxaban (Primary)
- Indications Thrombosis
- Focus Adverse reactions
- 03 Dec 2015 New trial record